233 related articles for article (PubMed ID: 22573355)
1. Prevalence of oral mucosal lesions in adults undergoing highly active antiretroviral therapy in Hong Kong.
Perera M; Tsang PC; Samaranayake L; Lee MP; Li P
J Investig Clin Dent; 2012 Aug; 3(3):208-14. PubMed ID: 22573355
[TBL] [Abstract][Full Text] [Related]
2. The prevalence of HIV associated oral lesions among adults in the era of HAART.
Mthethwa SR; Wanjau J; Chabikuli N
SADJ; 2013 Sep; 68(8):364-71. PubMed ID: 24660404
[TBL] [Abstract][Full Text] [Related]
3. Impact of PI and NNRTI HAART-based therapy on oral lesions of Brazilian HIV-infected patients.
Ortega KL; Vale DA; Magalhães MH
J Oral Pathol Med; 2009 Jul; 38(6):489-94. PubMed ID: 19453845
[TBL] [Abstract][Full Text] [Related]
4. Oral lesions in Brazilian HIV-infected children undergoing HAART.
Miziara ID; Filho BC; Weber R
Int J Pediatr Otorhinolaryngol; 2006 Jun; 70(6):1089-96. PubMed ID: 16406081
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of oral lesions in HIV patients related to CD4 cell count and viral load in a Venezuelan population.
Bravo IM; Correnti M; Escalona L; Perrone M; Brito A; Tovar V; Rivera H
Med Oral Patol Oral Cir Bucal; 2006 Jan; 11(1):E33-9. PubMed ID: 16388291
[TBL] [Abstract][Full Text] [Related]
6. Oral lesions in HIV/AIDS patients undergoing highly active antiretroviral treatment including protease inhibitors: a new face of oral AIDS?
Ceballos-Salobreña A; Gaitán-Cepeda LA; Ceballos-Garcia L; Lezama-Del Valle D
AIDS Patient Care STDS; 2000 Dec; 14(12):627-35. PubMed ID: 11119429
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of oral and perioral manifestations in HIV positive adults at Tikur Anbessa Teaching Hospital Addis Ababa, Ethiopia.
Guteta S; Feleke Y; Fekade D; Neway M; Diro E
Ethiop Med J; 2008 Oct; 46(4):349-57. PubMed ID: 19271399
[TBL] [Abstract][Full Text] [Related]
8. Oral lesions as clinical markers of highly active antiretroviral therapy failure: a nested case-control study in Mexico City.
Ramírez-Amador V; Ponce-de-León S; Anaya-Saavedra G; Crabtree Ramírez B; Sierra-Madero J
Clin Infect Dis; 2007 Oct; 45(7):925-32. PubMed ID: 17806063
[TBL] [Abstract][Full Text] [Related]
9. Oral HIV lesions and oral health behaviour of HIV-positive patients attending the Queen Elizabeth II Hospital, Maseru, Lesotho.
Kamiru HN; Naidoo S
SADJ; 2002 Dec; 57(11):479-82. PubMed ID: 12674869
[TBL] [Abstract][Full Text] [Related]
10. The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART)in a London clinic.
Ives NJ; Gazzard BG; Easterbrook PJ
J Infect; 2001 Feb; 42(2):134-9. PubMed ID: 11531320
[TBL] [Abstract][Full Text] [Related]
11. Delayed progression to death and to AIDS in a Hong Kong cohort of patients with advanced HIV type 1 disease during the era of highly active antiretroviral therapy.
Wong KH; Chan KC; Lee SS
Clin Infect Dis; 2004 Sep; 39(6):853-60. PubMed ID: 15472819
[TBL] [Abstract][Full Text] [Related]
12. Effect of PI-HAART on the prevalence of oral lesions in HIV-1 infected patients. A Greek study.
Nicolatou-Galitis O; Velegraki A; Paikos S; Economopoulou P; Stefaniotis T; Papanikolaou IS; Kordossis T
Oral Dis; 2004 May; 10(3):145-50. PubMed ID: 15089923
[TBL] [Abstract][Full Text] [Related]
13. The effect of antiretroviral therapy on the prevalence of oral manifestations in HIV-infected patients: a UK study.
Tappuni AR; Fleming GJ
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Dec; 92(6):623-8. PubMed ID: 11740479
[TBL] [Abstract][Full Text] [Related]
14. Oral lesions and immune reconstitution syndrome in HIV+/AIDS patients receiving highly active antiretroviral therapy. Epidemiological evidence.
Gaitan Cepeda LA; Ceballos Salobreña A; López Ortega K; Arzate Mora N; Jiménez Soriano Y
Med Oral Patol Oral Cir Bucal; 2008 Feb; 13(2):E85-93. PubMed ID: 18223535
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of oral lesions and periodontal diseases in HIV-infected patients on antiretroviral therapy.
Kroidl A; Schaeben A; Oette M; Wettstein M; Herfordt A; Häussinger D
Eur J Med Res; 2005 Oct; 10(10):448-53. PubMed ID: 16287607
[TBL] [Abstract][Full Text] [Related]
16. Risk indicators for oral candidiasis and oral hairy leukoplakia in HIV-infected adults.
Chattopadhyay A; Caplan DJ; Slade GD; Shugars DC; Tien HC; Patton LL
Community Dent Oral Epidemiol; 2005 Feb; 33(1):35-44. PubMed ID: 15642045
[TBL] [Abstract][Full Text] [Related]
17. Kaposi's sarcoma in patients with human immunodeficiency virus infection in Taiwan.
Lin CY; Chen MY; Hsieh SM; Sheng WH; Sun HY; Lo YC; Hung CC; Chang SC
J Microbiol Immunol Infect; 2009 Jun; 42(3):227-33. PubMed ID: 19812856
[TBL] [Abstract][Full Text] [Related]
18. Decline in the rate of oral opportunistic infections following introduction of highly active antiretroviral therapy.
Schmidt-Westhausen AM; Priepke F; Bergmann FJ; Reichart PA
J Oral Pathol Med; 2000 Aug; 29(7):336-41. PubMed ID: 10947250
[TBL] [Abstract][Full Text] [Related]
19. Oral manifestations of HIV infection in patients receiving highly active antiretroviral therapy (HAART) in Bahia, Brazil.
da Silva CA; Dourado I; Dahia SR; Harzheim E; Rutherford GW
J Public Health Dent; 2008; 68(3):178-81. PubMed ID: 18248345
[TBL] [Abstract][Full Text] [Related]
20. The Changing Clinical Spectrum of Human Immunodeficiency Virus (HIV)-Related Oral Lesions in 1,000 Consecutive Patients: A 12-Year Study in a Referral Center in Mexico.
Ramírez-Amador V; Esquivel-Pedraza L; Sierra-Madero J; Anaya-Saavedra G; González-Ramírez I; Ponce-de-León S
Medicine (Baltimore); 2003 Jan; 82(1):39-50. PubMed ID: 12544709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
